(Q47711606)

5 February 2018

title

Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodies (English)

1 reference

5 February 2018

1 reference

5

1 reference

5 February 2018

author name string

Rharbaoui F

1

1 reference

5 February 2018

Granier C

2

1 reference

5 February 2018

Kellou M

3

1 reference

5 February 2018

Mani JC

4

1 reference

5 February 2018

Madec AM

6

1 reference

5 February 2018

Boitard C

7

1 reference

5 February 2018

Pau B

8

1 reference

5 February 2018

Bouanani M

9

1 reference

5 February 2018

publication date

1 July 1998

1 reference

5 February 2018

published in

immunology Letters

1 reference

5 February 2018

volume

62

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

123-130

1 reference

5 February 2018

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionarily conserved residues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Analysis of active antibody concentration. Separation of affinity and concentration parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900036-4

7 January 2021

10.1016/S0165-2478(98)00036-4

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018